Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Community
/
United States
/
Healthcare
/
Viemed Healthcare
VMD
Viemed Healthcare
US Aging And Telehealth Will Expand Home Care
AN
AnalystHighTarget
Not Invested
Consensus Narrative from 2 Analysts
Published
18 May 25
Updated
20 Aug 25
0
Set Fair Value
0
votes
Share
AnalystHighTarget
's Fair Value
US$15.00
51.3% undervalued
intrinsic discount
20 Aug
US$7.31
Loading
1Y
-1.1%
7D
6.1%
Author's Valuation
US$15.0
51.3% undervalued
intrinsic discount
AnalystHighTarget Fair Value
View Valuation
Narrative
Updates
0
Valuator
Company Info
Notes
AnalystHighTarget Fair Value
US$15.0
51.3% undervalued
intrinsic discount
Future estimation in
3 Years
time period
Past
Future
0
401m
2014
2017
2020
2023
2025
2026
2028
Revenue US$400.8m
Earnings US$28.0m
Revenue
Profit Margin
Future PE
Revenue
% p.a.
0
Decrease
Increase
Current revenue growth rate
16.72%
Healthcare Services revenue growth rate
0.26%
Other Inputs & Calculation
Risk Level (Discount Rate)
Our default considers factors like the company's size, volatility, profitablity and country of operation.
Risk Level (Discount Rate)
%
0
Decrease
Increase
Current discount rate
6.78%
Calculation
US$28.02m
Earnings '28
x
24.76x
PE Ratio '28
=
US$693.90m
Market Cap '28
US$693.90m
Market Cap '28
/
38.34m
No. shares '28
=
US$18.10
Share Price '28
US$18.10
Share Price '28
Discounted to 2025 @ 6.78% p.a.
=
US$14.87
Fair Value '25